Our Know-how
We provide expertise for most relevant areas of drug development. This prepares us well for the upcoming endeavor.
Talent needed
We are looking for highly motivated individuals with expertise in bioinformatics, biostatistics and programming.
Nils Nesheim, PhD (Chief Executive Officer)
Experienced with mass spectrometry (2010-2011), good manufacturing practice (2014), molecular cancer research (2014-2020), late phase clinical research (2021-2022) and medical affairs (2022-2024).
Preclinical Research
Molecular cancer research in pre-clinical model systems and patient samples (liquid and tissue Biopsien)
Clinical Development
Monitoring clinical trials of drugs for diabetes, cancer and rheumatic disease (Phase II and III).
Medical Affairs
Medical Advisor responsibilities in the rare disease field (Pegvaliase-treatment for Phenylketonuria).